You appear to be offline. Some data may be unavailable until your connection is restored.

GILD

Stock

Gilead Sciences Inc

Create price alert
$167.95
-$1.78 (1.05%)
At close: Nov 12, 2026, 4:00 PM

Description

Gilead Sciences Inc. is a research‑driven biopharmaceutical company that discovers, develops and markets therapeutic medicines, most notably antiviral drugs for HIV/AIDS, hepatitis B and C, and more recently COVID‑19, as well as oncology, inflammatory and cell‑therapy products. It operates within the biotechnology and pharmaceutical sector, leveraging a strong R&D pipeline and strategic partnerships to bring new treatments to market. Gilead is recognized as a global leader in antiviral therapy, having built a dominant position with flagship HIV regimens and breakthrough hepatitis C cures, and is actively expanding its presence in cancer and specialty disease areas.

Dividend

1.90%annual yield
quarterly payout
Ex-Dividend: Dec 15, 2026
Payment: Dec 30, 2026
Payout: $0.82/share
Dividend history
AmountEx-DatePayment Date
$0.82Dec 15, 2026Dec 30, 2026
$0.82Sep 15, 2026Sep 29, 2026
$0.82Jun 15, 2026Jun 29, 2026

Track every GILD dividend

Get reminders ahead of GILD's ex-dividend and payment dates, so you always know when distributions are coming. Pair them with price and earnings alerts to keep your full income picture in view.

Other Healthcare stocks in the S&P 500